Connect with us

Biotechnology

New patent for Bristol-myers Squibb drug EVOTAZ

Avatar

Published

on

Copyright © DrugPatentWatch. Originally published at New patent for Bristol-myers Squibb drug EVOTAZ

Annual Drug Patent Expirations for EVOTAZ
Annual Drug Patent Expirations for EVOTAZ

Evotaz is a drug marketed by Bristol-myers Squibb and is included in one NDA. It is available from one supplier. There are two patents protecting this drug and one Paragraph IV challenge.

EVOTAZ drug price trends.

Drug patent litigation for EVOTAZ.

This drug has two hundred and thirty-seven patent family members in thirty-nine countries.

The generic ingredient in EVOTAZ is atazanavir sulfate; cobicistat. One supplier is listed for this compound. Additional details are available on the atazanavir sulfate; cobicistat profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Bristol-myers Squibb drug EVOTAZ

Source: https://www.drugpatentwatch.com/blog/new-patent-for-bristol-myers-squibb-drug-evotaz/

Biotechnology

New patent for Bayer Healthcare drug VITRAKVI

Avatar

Published

on

Copyright © DrugPatentWatch. Originally published at New patent for Bayer Healthcare drug VITRAKVI

Annual Drug Patent Expirations for VITRAKVI
Annual Drug Patent Expirations for VITRAKVI

Vitrakvi is a drug marketed by Bayer Hlthcare and Bayer Healthcare and is included in two NDAs. It is available from one supplier. There are twelve patents protecting this drug.

This drug has one hundred and thirty-four patent family members in forty-two countries.

The generic ingredient in VITRAKVI is larotrectinib sulfate. One supplier is listed for this compound. Additional details are available on the larotrectinib sulfate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Bayer Healthcare drug VITRAKVI

Source: https://www.drugpatentwatch.com/blog/new-patent-for-bayer-healthcare-drug-vitrakvi/

Continue Reading

Biotechnology

New patent for Boehringer Ingelheim drug OFEV

Avatar

Published

on

Copyright © DrugPatentWatch. Originally published at New patent for Boehringer Ingelheim drug OFEV

Annual Drug Patent Expirations for OFEV
Annual Drug Patent Expirations for OFEV

Ofev is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are five patents protecting this drug and one Paragraph IV challenge.

This drug has two hundred and twelve patent family members in fifty-one countries.

The generic ingredient in OFEV is nintedanib esylate. One supplier is listed for this compound. Additional details are available on the nintedanib esylate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Boehringer Ingelheim drug OFEV

Source: https://www.drugpatentwatch.com/blog/new-patent-for-boehringer-ingelheim-drug-ofev/

Continue Reading

Biotechnology

New patent expiration for Acorda drug INBRIJA

Avatar

Published

on

Copyright © DrugPatentWatch. Originally published at New patent expiration for Acorda drug INBRIJA

Annual Drug Patent Expirations for INBRIJA
Annual Drug Patent Expirations for INBRIJA

Inbrija is a drug marketed by Acorda and is included in one NDA. It is available from one supplier. There are eighteen patents protecting this drug.

This drug has one hundred and thirty-three patent family members in twenty-six countries.

The generic ingredient in INBRIJA is levodopa. One supplier is listed for this compound. Additional details are available on the levodopa profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Acorda drug INBRIJA

Source: https://www.drugpatentwatch.com/blog/new-patent-expiration-for-acorda-drug-inbrija/

Continue Reading
Nano Technology4 hours ago

Physicists make electrical nanolasers even smaller

Nano Technology4 hours ago

Nano-microscope gives first direct observation of the magnetic properties of 2D materials: Discovery means new class of materials and technologies

Nano Technology4 hours ago

Who stole the light? Self-induced ultrafast demagnetization limits the amount of light diffracted from magnetic samples at soft x-ray energies

Blockchain4 hours ago

Brace for it – Bitcoin Futures may be nearing a tipping point

Blockchain5 hours ago

Tron, Synthetix, VeChain Price Analysis: 19 September

AR/VR8 hours ago

Someone Remade ‘Among Us’ in VR and It’s Strangely More Fun Than the Original

AR/VR8 hours ago

Virtual Tours: The Key to a Successful School Marketing Plan

Crowdfunding10 hours ago

Spanish Financial Giant BBVA’s US Division Recognized as one of the Best Corporate Digital Banks in North America

Gaming12 hours ago

Evening Reading – September 18, 2020

AI13 hours ago

7 Awe Inspiring AI Techs That Transformed The Digital World

Entrepreneur14 hours ago

100X.VC Unveils Its Class 02 Investments

Payments14 hours ago

Here’s how Nasdaq-listed MicroStrategy went about buying $175m in Bitcoin

Esports14 hours ago

Lenovo Legion Sponsors G2 Esports as Hardware Partner

CNBC14 hours ago

Supreme Court Justice Ruth Bader Ginsburg dies at age 87

Energy15 hours ago

Shanghai Electric Showcases Smart Energy Solution at China International Industrial Expo on World’s Clean Up Day

Entrepreneur15 hours ago

Preventive Healthcare Market Dilating in India

Cannabis16 hours ago

5 weed products Tommy Chong can’t live without

Gaming16 hours ago

Shacknews Twitch Highlights: Rocket League, Fight Crab, and Quest 64

Entrepreneur16 hours ago

More gets 275 Crore INR From Amazon, Samara Capital

Big Data17 hours ago

TikTok filed a complaint against Trump administration to block U.S. ban: Bloomberg News

Blockchain18 hours ago

Seoul Police Summons Bithumb Chairman For Interrogation

Cyber Security19 hours ago

6 Crucial password security tips for everyone

CNBC19 hours ago

‘Thank you, RBG’: Leaders react with sadness, shock to Ruth Bader Ginsburg’s death

Gaming19 hours ago

Shack Chat: What’s your reaction to the September PlayStation 5 Showcase?

Cleantech19 hours ago

Ford Mustang Mach-E Easily Goes 300+ Miles In Norway

Gaming19 hours ago

Apple and Sony Events – The TouchArcade Show #462

Esports19 hours ago

Here’s the schedule for the 2020 League of Legends World Championship

Gaming19 hours ago

Weekend PC Download Deals for Sept. 18: Steam Pirate Sale

Gaming19 hours ago

Shacknews Dump – September 18, 2020

Crowdfunding19 hours ago

India-Based Insurtech ACKO Secures $60 Million Through Latest Funding Round Led By Munich Re Ventures

Crowdfunding20 hours ago

Google Temporarily Removes Paytm Mobile App from Play Store Due to Supposedly Being in Violation For Gambling

Gaming20 hours ago

TouchArcade Game of the Week: ‘Songbringer’

CNBC20 hours ago

In Photos: Crowd gathers in front of the Supreme Court to mourn Justice Ruth Bader Ginsburg

CoinTelegraph20 hours ago

Pinned below $11K, Bitcoin price plays second fiddle to Uniswap (UNI)

CNBC21 hours ago

Trump nominee to replace Ruth Bader Ginsburg on Supreme Court will get Senate vote, McConnell says

Cleantech21 hours ago

Indian Government May Put EV Chargers At 69,000 Gas Pumps

Blockchain22 hours ago

The Last Time This On-Chain Metric Was This Low, Bitcoin Surged 150%

Crowdfunding22 hours ago

Digital Transformation: Qatar Financial Center Regulatory Authority to Migrate Online Services to Microsoft Cloud

Gaming22 hours ago

Call of Duty Cold War VS. Modern Warfare: The Biggest Differences

Gaming22 hours ago

What The Hell Happened To Splinter Cell

Trending